Introduction and aim
Chronic skin diseases are associated with significant morbidity in the form of physical discomfort and impairment of patient\'s quality of life (QOL). This study was aimed to assess the impact of various chronic dermatoses on the QOL.
Materials and methods
This was a hospital-based, cross-sectional study done on 180 consenting outdoor patients between 20 and 60 years of age clinically diagnosed to have a chronic skin disorder, including acne, psoriasis, atopic dermatitis (AD), vitiligo, chronic urticaria (CU), or androgenetic alopecia (AGA) for more than 6 months duration. Quality of life was assessed by using the World Health Organization (WHO) QOL-BREF (Hindi version) which had four domains—physical, psychological, social relationship, and environmental health.
Out of total 180 cases, 100 (55.6%) were males and 80 were females (44.4%). Most cases (43.3%) were in the age group of 20 to 30 years. Urban patients (143, 79.4%) were more than rural patients (37, 20.6%). Chronic urticaria and AGA had significant impact on psychosocial domain.
All the six dermatoses showed impact on the patient\'s QOL. This raises the need to have an assessment by psychologists and counselors within dermatology services in treating the chronic dermatoses.
How to cite this article
Jain S, Soni S, Nijhawan M, Agrawal S. Assessment of Quality of Life in Chronic Dermatoses. J Mahatma Gandhi Univ Med Sci Tech 2017;2(2):71-77.
Wilson E. Lectures on dermatology. Vol. 1. London: J & A Churchill; 1871. pp. 106-113.
The World Health Organization Quality of Life Assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995 Nov;41(10):1403-1409.
Halioua B, Beumont MG, Lunel F. Int J Dermatol 2000 Nov;39(11):801-806.
WHOQOL Group. Development of the WHOQOL: rationale and current status. Int J Ment Health 1994;23(3):24-56.
The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998 Jun;46(12):1569-1585.
Noerholm V, Groenvold M, Watt T, Bjorner JB, Rasmussen NA, Bech P. Quality of life in the Danish general population-normative data and validity of WHOQOL-BREF using Rasch and item response theory models. Qual Life Res 2004 Mar;13(2):531-540.
Koo JY, Shellow WV, Hallman CP, Edwards JE. Alopecia areata and increased prevalence of psychiatric disorders. Int J Dermatol 1994 Dec;33(12):849-850.
Tan JK. Psychological impact of acne vulgaris: evaluating the evidence. Skin Therapy Lett 2004 Aug-Sep;9(7):1-3, 9.
Tallab TM. Beliefs, perceptions and psychological impact of acne vulgaris among patients in the Assir region of Saudi Arabia. West Afr J Med 2004 Jan-Mar;23(1):85-87.
Pawin H, Chivot M, Beylot C, Faure M, Poli F, Revuz J, Dréno B. Living with acne: a study of adolescents’ personal experience. Dermatology 2007;215(4):308-314.
Kubba R, Bajaj AK, Thappa DM, Sharma R, Vedamurthy M, Dhar S, Criton S, Fernandez R, Kanwar AJ, Khopkar U, et al. Acne in India: guidelines for management – IAA consensus document. Indian J Dermatol Venereol Leprol 2009 Jan;75 (Suppl 1):1-62.
Tasoula E, Gregoriou S, Chalikias J, Lazarou D, Danopoulou I, Katsambas A, Rigopoulos D. The impact of acne vulgaris on quality of life and psychic health in young adolescents in Greece. Results of a population survey. An Bras Dermatol 2012 Nov-Dec;87(6):862-869.
Behnam B, Taheri R, Ghorbani R, Allameh P. Psychological impairments in the patients with acne. Indian J Dermatol 2013 Jan;58(1):26-29.
Manjula VD, Sreekiran S, Saril PS, Sreekanth MP. A study of psoriasis and quality of life in a tertiary care teaching hospital of Kottayam, Kerala. Indian J Dermatol 2011 Jul;56(4):403-406.
Rakhesh SV, D'Souza M, Sahai A. Quality of life in psoriasis: a study from South India. Indian J Dermatol Venereol Leprol 2008 Nov-Dec;74(6):600-606.
Mozaffari H, Pourpak Z, Pourseyed S, Farhoodi A, Aghamhammadi A, Movahadi M, Ghaaraghozloo M, Moin M. Quality of life in atopic dermatitis patients. J Microbiol Immunol Infect 2007 Jun;40(3):260-264.
Coghi S, Bortoletto MC, Sampaio SA, Andrade Junior HF, Aoki V. Quality of Life is severely compromised in adult patients with atopic dermatitis in Brazil, especially due to mental components. Clinics (Sao Paulo) 2007 Jun;62(3):235-242.
Karelson M, Silm H, Kingo K. Quality of life and emotional state in vitiligo in an Estonian sample: comparison with psoriasis and healthy controls. Acta Derm Venereol 2013 Jul 6;93(4):446-450.
Al-Mubarak L, Al-Mohanna H, Al-Issa A, Jabak M, Mulekar SV. Quality of life in Saudi vitiligo patients. J Cutan Aesthet Surg 2011 Jan;4(1):33-37.
Sampogna F, Raskovic D, Guerra L, Pedicelli C, Tabolli S, Leoni L, Alessandroni L, Abeni D. Identification of categories at risk for high quality of life impairment in patients with vitiligo. Br J Dermatol 2008 Aug;159(2):351-359.
Ramakrishna P, Rajni T. Psychiatric morbidity and quality of life in vitiligo patients. Indian J Psychol Med 2015 Jan-Mar;37(1):111.
Ue AP, Souza PK, Rotta O, Furlani Wde J, Lima AR, Sabbag DS. Quality of life assessment in patients with chronic urticaria. An Bras Dermatol 2011 Sep-Oct;86(5):897-904.
Ben-Shoshan M, Blinderman I, Raz A. Psychosocial factors and chronic spontaneous urticaria: a systematic review. Eur J Allergy Clin Immunol 2013 Feb;68(2):131-141.
Sawant N, Chikhalkar S, Mehta V, Ravi M, Madke B, Khopkar U. Androgenetic alopecia: quality-of-life and associated lifestyle patterns. Int J Trichol 2010 Jul;2(2):81-85.
Cash TF, Price VH, Savin RC. Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects. J Am Acad Dermatol 1993 Oct;29(4):568-575.
Van Der Donk J, Hunfeld JA, Passchier J, Knegt-Junk KJ, Nieboer C. Quality of life and maladjustment associated with hair loss in women with alopecia androgenetica. Soc Sci Med 1994 Jan;38(1):159-163.
Van Passchier J, Dutree-Meulenberg RO, Stolz E, Verhage F. Psychological characteristics of men with alopecia androgenetica and their modification. Int J Dermatol 1991 Jan;30(1):22-28.
Rao GP. Spinal intramedullary tuberculous lesion: medical management. Report of four cases. J Neurosurg 2000;93(Suppl 1):137-141.
Jena A, Banerji AK, Tripathi RP, Gulati PK, Jain RK, Khushu S, Sapra ML. Demonstration of intramedullary tuberculomas by magnetic resonance imaging: a report of two cases. Br J Radiol 1991;64(762):555-558.
Citow JS, Ammirati M. Intramedullary tuberculoma of the spinal cord: case report. Neurosurgery 1994 Aug;35(2):327-330.
Medhi S, Goswami B, Das AK, Singh TB, Husain SA, Sehgal A, Kar P. New insights into hepatitis C virus infection in the tribal-dominant part of Northeast India. Arch Virol 2012 Nov;157(11):2083-2093.
Raghuraman S, Abraham P, Sridharan G, Ramakrishna BS. Hepatitis C virus genotype 6 infection in India. Indian. J Gastroenterol 2005 Mar-Apr;24(2):72-75.
Raghuraman S, Abraham P, Sridharan G, Daniel HD, Ramakrishna BS, Shaji RV. HCV genotype 4 — an emerging threat as a cause of chronic liver disease in Indian (south) patients. J Clin Virol 2004 Dec;31(4):253-258.
Umer M, Iqbal M. Hepatitis C virus prevalence and genotype distribution in Pakistan: comprehensive review of recent data. World J Gastroenterol 2016 Jan;22(4):1684-1700.
Esmaeilzadeh A, Erfanmanesh M, Ghasemi S, Mohammadi F. Serological assay and genotyping of hepatitis C virus in infected patients in Zanjan province. Hepat Mon 2014 Sep;14(9):e17323.
Mittal G, Gupta P, Gupta R, Ahuja V, Mittal M, Dhar M. Seroprevalence and risk factors of hepatitis B and hepatitis C virus infections in Uttarakhand, India. J Clin Exp Hepatol 2013 Dec;3(4):296-300.
Sarma MP, Asim M, Medhi S, Bharathi T, Diwan R, Kar P. Viral genotypes and associated risk factors of hepatocellular carcinoma in India. Cancer Bio Med 2012 Sep;9(3):172-181.
Ullah, Mi Hasan, F Najmudin, Alam, MM SSZZ, Rana, MS Nawaz, M Rehman S and Shah A A. Seroprevalence of Hepatitis C Virus Infection in Kohat Division, Khyber Pakhtoonkhwa, Pakistan. Pakistan J Zool 2016;.48(6):1721-1725.
Ramarokoto CE, Rakotomanana F, Ratsitorahina M, Raharimanga V, Razafindratsimandresy R, Randremanana R, Rakoto-Andrianarivelo M, Rousset D, Andrianaja V, Richard V, et al. Seroprevalence of hepatitis C and associated risk factors in urban areas of Antananarivo, Madagascar. BMC Infect Dis 2008 Feb;8:25.
Singh P, Kaur R, Kaur A. Frequency distribution of Hepatitis C virus in different geographical regions of Punjab: retrospective study from a tertiary care centre in North India. J Nat Sci Biol Med 2014 Jan;5(1):56-58.
Sandhu R, Dahiya S. Prevalence of anti-hepatitis C virus antibodies among inpatients and outdoor attendees of a tertiary care institute. Br Biomed Bull 2015 Jan;3(1):8-14.
Da Ros CT, Schmitt CdaS. Global epidemiology of sexually transmitted diseases. Asian J Androl 2008 Jan;10(1): 110-114.
Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis 2010 Feb;14(1):1-21.
Khan IA, Pilli S A S, Rampal R, Chauhan SK, Tiwari V, Mouli VP, Kedia S, Nayak B, Das P, Makharia GK, et al. Prevalence and Association of Mycobacterium avium subspecies paratuberculosis with disease course in patients with ulcero-constrictive ileocolonic disease. PLoS One 2016 Mar;11(3):e0152063.
Ramadass B, Chittaranjan S, Subramanian V, Ramakrishna BS. Fecal polymerase chain reaction for Mycobacterium tuberculosis IS6110 to distinguish Crohn's disease from intestinal tuberculosis. Indian J Gastroenterol 2010 Jul;29(4):152-156.
Jin XJ, Kim JM, Kim HK, Kim L, Choi SJ, Park IS, Han JY, Chu YC, Song JY, Kwon KS, et al. Histopathology and TB-PCR kit analysis in differentiating the diagnosis of intestinal tuberculosis and Crohn's disease. World J Gastroenterol 2010 May;16(20):2496-2503.
Jin T, Fei B, Zhang Y, He X. The diagnostic value of polymerase chain reaction for Mycobacterium tuberculosis to distinguish intestinal tuberculosis from Crohn's disease: a meta-analysis. Saudi J Gastroenterol 2017 Jan-Feb;23(1):3-10.
Sechi LA, Mura M, Tanda F, Lissia A, Solinas A, Fadda G, Zanetti S. Identification of Mycobacterium avium subsp. paratuberculosis in biopsy specimens from patients with Crohn's disease identified by in situ hybridization. J Clin Microbiol 2001 Dec;39(12):4514-4517.
Sechi LA, Mura M, Tanda E, Lissia A, Fadda G, Zanetti S. Mycobacterium avium sub. paratuberculosis in tissue samples of Crohn's disease patients. New Microbiol 2004 Jan;27(1):75-77.
Sechi LA, Scanu AM, Molicotti P, Cannas S, Mura M, Dettori G, Fadda G, Zanetti S. Detection and Isolation of Mycobacterium avium subspecies paratuberculosis from intestinal mucosal biopsies of patients with and without Crohn's disease in Sardinia. Am J Gastroenterol 2005 Jul;100(7):1529-1536.
Pulimood AB, Peter S, Rook GW, Donoghue HD. In situ PCR for Mycobacterium tuberculosis in endoscopic mucosal biopsy specimens of intestinal tuberculosis and Crohn disease. Am J Clin Pathol 2008 Jun;129(6):846-851.
Aimaiti R, Qin L, Cao T, Yang H, Wang J, Lu J, Huang X, Hu Z. Identification and application of ssDNA aptamers against H37Rv in the detection of Mycobacterium tuberculosis. Appl Microbiol Biotechnol 2015 Nov;99(21):9073-9083.
Mozioglu E, Gokmen O, Tamerler C, Kocagoz ZT, Akgoz M. Selection of nucleic acid aptamers specific for Mycobacterium tuberculosis. Appl Biochem Biotechnol 2016 Feb;178(4):849-864.
Tang XL, Wu SM, Xie Y, Song N, Guan Q, Yuan C, Zhou X, Zhang XL. Generation and application of ssDNA aptamers against glycolipid antigen ManLAM of Mycobacterium tuberculosis for TB diagnosis. J Infect 2016 May;72(5):573-586.
Pan Q, Wang Q, Sun X, Xia X, Wu S, Luo F, Zhang XL. Aptamer against mannose-capped lipoarabinomannan inhibits virulent Mycobacterium tuberculosis infection in mice and rhesus monkeys. Mol Ther 2014 May;22(5):940-951.
Perkins AC, Missailidis S. Radiolabelled aptamers for tumour imaging and therapy. Q J Nucl Med Mol Imaging 2007 Dec;51(4):292-296.
Calzada V, Moreno M, Newton J, González J, Fernández M, Gambini JP, Ibarra M, Chabalgoity A, Deutscher S, Quinn T, et al. Development of new PTK7-targeting aptamer-fluorescent and radiolabelled probes for evaluation as molecular imaging agents: lymphoma and melanoma in vivo proof of concept. Bioorg Med Chem 2016 Dec;25(3):1163-1171.
Lele, RD. Imaging tuberculosis with radiolabelled aptamers. In: Kulkarni SV, editor. Pursuit of excellence—an autobiography. Mumbai: Granthali Woollen Mill Public School; 2017. pp. 154-156.
Fogel R, Limson J. Developing biosensors in developing countries: South Africa as a case study. Biosensors (Basel) 2016 Feb;6(1):E5.
Chen F, Zhou J, Luo F, Mohammed AB, Zhang XL. Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis. Biochem Biophys Res Commun 2007 Jun;357(3):743-748.
Baig IA, Moon JY, Lee SC, Ryoo SW, Yoon MY. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxy acid synthase. Biochim Biophys Acta 2015 Oct;1854(10 Pt A):1338-1350.
Sohal JS, Sheoran N, Narayanasamy K, Brahmachari V, Singh S, Subodh S. Genomic analysis of local isolate of Mycobacterium avium subspecies paratuberculosis. Vet Microbiol 2009 Mar;134(3-4):375-382.